Latest Tatva Chintan Pharma stock price

Tatva Chintan Pharma P/E Ratio

TATVA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
175.53
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 175.53
Current Price ₹1286.40
EPS (TTM) ₹2.44
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 101.18
Historical Range 48.84 - 127.61
Percentile 100.0%

Sector Context

Sector Average 305.36
Sector Median 30.08
Sector Rank #11 of 130
Sector Percentile 8.5%

Earnings Breakdown (TTM)

TTM EPS ₹7.23
Sept 2025 ₹4.24
Mar 2025 ₹0.44

Key P/E Ratio Insights for Tatva Chintan Pharma

  • Stock appears overvalued with PE of 175.53, suggesting caution for new investments
  • Current PE is 73.5% above historical average
  • Trading at discount to sector average PE of 305.36

View the TATVA equity price for detailed stock performance.

P/E Ratio Historical Trend for Tatva Chintan Pharma

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2023 127.61 16.85 ₹2150.30 NSE High
2022 127.08 20.77 ₹2639.45 NSE High
2021 48.84 47.34 ₹2312.20 NSE High

Sector P/E Ratio Comparison

Comparing Tatva Chintan Pharma with other companies in Chemicals sector
Sector Average
305.36
Sector Median
30.08
Lowest P/E
1.06
Highest P/E
25147.5
Companies
130
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
GOCL Corporation GOCLCORP 1.06 ₹1,422 Low
Zuari Agro Chemicals ZUARI 1.28 ₹1,362 Low
AVI Polymers AVI 2.54 ₹8 Low
Prolife Industries PROLIFE 6.46 ₹32 Low
Agro Phos AGROPHOS 6.98 ₹77 Low
EID Parry EIDPARRY 8.12 ₹17,695 Low
Tamilnadu Petroproducts TNPETRO 8.66 ₹948 Low
Southern Petrochemical I… SPIC 8.86 ₹1,653 Low
GHCL GHCL 9.03 ₹5,117 Low
Deepak Chemtex DEEPAKCHEM 9.21 ₹111 Low